Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro

MA Alamri, Tahir ul Qamar M, MU Mirza, R Bhadane, SM Alqahtani, I Muneer, M Froeyen, Outi Salo-Ahen

Research output: Contribution to journal › Article › Scientific › peer-review

84 Citations (Scopus)
62 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science